A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Repeated-dose Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Three Different Dosing Regimens of Inhaled Indacaterol Maleate in Patients With Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2015
At a glance
- Drugs Indacaterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 21 Jun 2012 Inclusion and exclusion criteria ammened as reported by European Clinical Trials Database record .
- 22 Jul 2010 Actual patient number is 191 as reported by ClinicalTrials.gov.
- 22 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.